FDA D.I.S.C.O. Burst Edition: FDA approval of Lenvima (lenvatinib) in combination with Keytruda (pembrolizumab) for first-line treatment of adult patients with advanced renal cell carcinoma
0:00
3:30
Listen to a soundcast of the August 10, 2021 FDA approval of Lenvima (lenvatinib) in combination with Keytruda (pembrolizumab) for first-line treatment of adult patients with advanced renal cell carcinoma
D'autres épisodes de "FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)"
Ne ratez aucun épisode de “FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.